Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sleep apnea may harm your brain: new study investigates

NCT ID NCT07364318

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how obstructive sleep apnea (OSA) affects thinking, memory, and other brain functions in adults. Researchers will follow 30 people with newly diagnosed OSA for 12 months to see if using a breathing device (positive airway pressure therapy) helps protect the brain. Participants will take memory and thinking tests, have brain scans, and give blood and saliva samples. The goal is to better understand the link between sleep apnea and cognitive decline.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with newly diagnosed OSA who have no history of other chronic diseases except for overweight and obesity, are not taking any medication, and are aged between 18 and 65 years.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Informed consent. 2. Age 18 - 65 years. 3. Newly diagnosed OSA according to the criteria of the American Academy of Sleep Medicine Guidelines (overnight PSG with an AHI ≥5 events per hour, hypopneas defined by ≥ 10 seconds of airflow reduction accompanied by ≥ 3% desaturation or an arousal). 4. Able to accomplish relevant tests and follow-up. Exclusion Criteria: 1. History of any chronic disease other than overweight and obesity. 2. Severe psychiatric condition that could affect cognitive functions. 3. Chronic use of medication or nicotine that may affect the study results. 4. Prior neuropsychological assessment less than 6 months before the start of the research. 5. Prior therapy for OSA (i.e., CPAP, upper airway surgery, or oral appliance). 6. Motor or sensory deficits that would significantly complicate test administration. 7. Patients who do not have Slovak as their native language actively used in daily communication. 8. Considered by the study team as not suitable for enrollment based on clinical judgment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive functions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 1st Department of Neurology, Faculty of Medicine, Comenius University and University Hospital Bratislava, Slovakia

    RECRUITING

    Bratislava, 813 72, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.